Research, perspectives, and practical insights on performance, recovery, and longevity.
Editor's Pick
After multiple knee injuries, surgeries, and setbacks, I've learned that physical recovery and trusting your body again aren't always the same thing.
Read Article
It started with a question in a Facebook peptide group: "Everyone using Chinese manufactured Peptides?" Sixty-eight comments later, the thread had split into two camps — "it's all from China, they're lying if they say otherwise" versus "not everything is Chinese, my US seller makes it here."
Layering specific cell-signaling peptides can maximize their clinical efficacy, but what exact mechanics make a protocol truly synergistic?
Entrepreneur Sean Rakidzich rebuilt his health after workaholism and alcohol. His story reveals why peptides are attracting attention, and where evidence ends and hype begins.
Retatrutide targets three metabolic pathways and early trial results are turning heads. Here’s what makes it different from today’s GLP-1s.
Retatrutide produced weight-loss results approaching those associated with bariatric surgery—but its third metabolic target may change both its benefits and risks.
The weight can come back fast after GLP-1 treatment ends. What you do before your final dose could determine how much you regain.
Exploring whether GLP-1 medications can reduce cancer risk amidst compelling research findings.
The scale may be dropping, but is your strength going with it? These ten GLP-1 nutrition rules help protect what weight loss can quietly take.
5 matching articles
The Rebuild
For athletes and high performers building long-term health.
Sign up for The Rebuild
Educational emails on performance, recovery, and longevity.
Join the list for future issues of The Rebuild. Unsubscribe anytime. See our privacy policy.
Educational content only. Not medical advice.
